Precision medicine was the theme of the 2014 meeting of the European Society for Medical Oncology (ESMO), assembling 19,859 participants from nearly 134 countries worldwide.

A conference report by Professor Giuseppe Curigliano published in ecancermedicalscience covers the key abstracts of this outstanding meeting, summarising the most important research developments across the range of cancer modalities.

Cancer is a “spectrum” of diseases, and the precise application of personalised medicine must evolve to meet its challenges.

Emerging research on the characterisation of the immune system’s response to cancer has impacted studies across every type of cancer.

Read the conference report to learn more about the key developments of ESMO 2014.